iBio
IBIO
#10074
Rank
S$34.96 M
Marketcap
S$1.56
Share price
-6.25%
Change (1 day)
-55.14%
Change (1 year)

iBio (IBIO) - Net assets

Net assets on the balance sheet as of June 2025 : S$19.28 Million

According to iBio's latest financial reports the company has S$19.28 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

iBio - Net assets on balance sheet (from 2008 to 2025)

Net assets by year

Year Net assets Change
2024-06-30$S$28.88 M38.9%
2023-06-30$S$20.79 M-76.43%
2022-06-30$S$88.25 M-39.55%
2021-06-30$S$0.14 B85.05%
2020-06-30$S$78.89 M2275.23%
2019-06-30$S$3.32 M-84.92%
2018-06-30$S$22.02 M79.51%
2017-06-30$S$12.27 M-62.11%
2016-06-30$S$32.39 M114.04%
2015-06-30$S$15.13 M99.02%
2014-06-30$S$7.6 M18.23%
2013-06-30$S$6.43 M-17.72%
2012-06-30$S$7.81 M3139.17%
2011-06-30$S$0.24 M-83.85%
2010-06-30$S$1.49 M-76.43%
2009-06-30$S$6.33 M-175.1%
2008-06-30$-S$8.45 Million26.99%
2007-06-30$-S$6.65 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Genocea Biosciences
GNCA
S$16.04 M-16.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.75 B 3,814.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$102.73 B 532,675.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
S$0.11 B 471.81%๐Ÿ‡บ๐Ÿ‡ธ USA